Suppr超能文献

奈替米星在肾功能损害患者及透析患者中的药代动力学。

Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.

作者信息

Luft F C, Brannon D R, Stropes L L, Costello R J, Sloan R S, Maxwell D R

出版信息

Antimicrob Agents Chemother. 1978 Sep;14(3):403-7. doi: 10.1128/AAC.14.3.403.

Abstract

The pharmacokinetics of netilmicin were examined in 25 adult subjects, 7 normal subjects, and 18 patients with renal impairment. Five were dialysis patients who were studied on and off dialysis. Netilmicin, 2 mg/kg, was infused intravenously over 1 h. The peak serum concentration ranged from 9 to 11 mug/ml. The mean biological half-life of netilmicin for subjects with a creatinine clearance (Ccr) > 70 ml/min was 2.7 h, for those with Ccr > 25 < 70 ml/min it was 10 h, for those with Ccr > 4 < 25 ml/min it was 32 h, and for those who were anephric it was 42 h. Ccr was correlated positively with the elimination constant and the drug's serum clearance. It was negatively correlated with the drug's volume of distribution. The dialyzer clearance of netilmicin was positively correlated with plasma flow rate and was similar to values previously reported for gentamicin. Netilmicin behaves in a fashion similar to other aminoglycosides. Therapeutic guidelines are suggested.

摘要

对25名成年受试者(7名正常受试者和18名肾功能不全患者)进行了奈替米星的药代动力学研究。其中5名是透析患者,分别在透析时和透析后进行了研究。以2mg/kg的剂量将奈替米星静脉输注1小时。血清峰值浓度在9至11μg/ml之间。肌酐清除率(Ccr)>70ml/min的受试者中,奈替米星的平均生物半衰期为2.7小时;Ccr>25<70ml/min的受试者中,其平均生物半衰期为10小时;Ccr>4<25ml/min的受试者中,其平均生物半衰期为32小时;无肾的受试者中,其平均生物半衰期为42小时。Ccr与消除常数及药物的血清清除率呈正相关。它与药物的分布容积呈负相关。奈替米星的透析器清除率与血浆流速呈正相关,与先前报道的庆大霉素的值相似。奈替米星的行为方式与其他氨基糖苷类药物相似。文中提出了治疗指南。

相似文献

1
Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.
Antimicrob Agents Chemother. 1978 Sep;14(3):403-7. doi: 10.1128/AAC.14.3.403.
2
Pharmacokinetics of netilmicin in renal insufficiency and haemodialysis.
Clin Pharmacokinet. 1978 Sep-Oct;3(5):395-406. doi: 10.2165/00003088-197803050-00005.
4
Predicted tissue accumulation of netilmicin in patients.
Antimicrob Agents Chemother. 1981 Dec;20(6):714-7. doi: 10.1128/AAC.20.6.714.
5
Multicompartment pharmacokinetics of netilmicin.
Eur J Clin Pharmacol. 1979 Nov;16(5):331-4. doi: 10.1007/BF00605631.
6
Pharmacokinetics of netilmicin in the presence of normal or impaired renal function.
Antimicrob Agents Chemother. 1978 Jul;14(1):40-4. doi: 10.1128/AAC.14.1.40.
8
Comparison of netilmicin and gentamicin pharmacokinetics in humans.
Antimicrob Agents Chemother. 1980 Feb;17(2):184-7. doi: 10.1128/AAC.17.2.184.
9
Netilmicin and gentamicin multidose kinetics in normal subjects.
Clin Pharmacol Ther. 1983 Nov;34(5):644-50. doi: 10.1038/clpt.1983.227.
10
Kinetics of netilmicin and gentamicin.
Clin Pharmacol Ther. 1978 May;23(5):591-7. doi: 10.1002/cpt1978235591.

引用本文的文献

1
Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients.
Antimicrob Agents Chemother. 2012 Apr;56(4):1862-9. doi: 10.1128/AAC.05634-11. Epub 2012 Jan 30.
2
Population pharmacokinetics of netilmicin in short-term prophylactic treatment.
Br J Clin Pharmacol. 2003 Jun;55(6):552-9. doi: 10.1046/j.1365-2125.2003.01783.x.
4
Predicted tissue accumulation of netilmicin in patients.
Antimicrob Agents Chemother. 1981 Dec;20(6):714-7. doi: 10.1128/AAC.20.6.714.
5
Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
Antimicrob Agents Chemother. 1980 Feb;17(2):217-25. doi: 10.1128/AAC.17.2.217.
6
7
Serum level monitoring of antibacterial drugs. A review.
Clin Pharmacokinet. 1984 Nov-Dec;9(6):475-92. doi: 10.2165/00003088-198409060-00001.
8
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1989 Nov;38(5):703-56. doi: 10.2165/00003495-198938050-00003.
9
Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations.
Clin Pharmacokinet. 1990 Feb;18(2):104-17. doi: 10.2165/00003088-199018020-00002.
10
Isepamicin disposition in subjects with various degrees of renal function.
Antimicrob Agents Chemother. 1991 Nov;35(11):2382-7. doi: 10.1128/AAC.35.11.2382.

本文引用的文献

1
Pharmacokinetics of gentamicin: distribution and plasma and renal clearance.
J Infect Dis. 1971 Dec;124 Suppl:S70-6. doi: 10.1093/infdis/124.supplement_1.s70.
2
[Renal excretion of gentamicin in man].
Dtsch Med Wochenschr. 1972 Oct 6;97(40):1496-8 passim. doi: 10.1055/s-0028-1107589.
3
Simplified assay for gentamicin in the presence of other antibiotics.
Antimicrob Agents Chemother. 1973 May;3(5):559-61. doi: 10.1128/AAC.3.5.559.
4
Serum protein binding of the aminoglycoside antibiotics.
Antimicrob Agents Chemother. 1972 Sep;2(3):214-6. doi: 10.1128/AAC.2.3.214.
6
Comparative pharmacokinetics of tobramycin and gentamicin.
Clin Pharmacol Ther. 1973 May-Jun;14(3):396-403. doi: 10.1002/cpt1973143396.
7
Tobramycin in renal impairment.
Am J Med Sci. 1975 May-Jun;269(3):317-21. doi: 10.1097/00000441-197505000-00004.
8
Comparative nephrotoxicities of netilmicin and gentamicin in rats.
Antimicrob Agents Chemother. 1976 Nov;10(5):845-9. doi: 10.1128/AAC.10.5.845.
9
Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.
Antimicrob Agents Chemother. 1976 Nov;10(5):827-36. doi: 10.1128/AAC.10.5.827.
10
Pharmacokinetics of amikacin in patients with normal or impaired renal function: radioenzymatic acetylation assay.
J Infect Dis. 1976 Nov;134 SUPPL:S323-30. doi: 10.1093/infdis/135.supplement_2.s323.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验